The content on this site is intended for healthcare professionals only
Jeremy Heinerich speaks to ecancer at the APAO 2019 meeting in Boston about the opportunities this event can provide for physician associates (PAs).
He outlines his role within the organisation, along with the panel discussion that took place at this year's meeting which involved a variety of healthcare professionals.
Heinerich also mentions some of the novel treatments that are emerging in the haematology field, including the use of oral chemotherapy drugs.
Durable responses in aRCC, how do we optimise treatment?
Perspectives on advance care planning for advanced cancer in the Philippines
Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer
Importance of MRD in newly developed multiple myeloma
ASCO 2024: Two studies report on isatuximab combos in transplant-ineligible patients with newly diagnosed multiple myeloma
Synthetic biology and precision medicine in blood and gynaecological cancers
The evolving paradigm in management of Multiple Myeloma
Haemato-oncological Cancers
Lung Cancer
